There is mounting evidence for a possible role for Campylobacter concisus in Crohn's disease (CD). However, the pathogenic potential of C. concisus remains disputed due to its presence in healthy subjects. It is documented that genetic diversity exists within this species, with some strains possessing putative virulence determinants such as exotoxin 9/DnaI that may enable them to persist intracellularly in host cells. In order to clarify this, we employed real-time PCR to determine C. concisus and exotoxin 9 levels within faecal samples of CD patients and healthy controls, and correlated these levels with abundances of microbial taxa identified in a subset of subjects. Both C. concisus and exotoxin 9 levels were found to be higher in CD patients than healthy controls, suggesting not only that CD patients had a greater abundance of C. concisus but also that their strains were likely to be more virulent. Moreover, C. concisus levels correlated with the exotoxin 9 levels in CD patients but not in healthy controls, indicating that healthy controls were colonized by non-virulent C. concisus strains. Correlations with the intestinal microbiota found C. concisus levels to correlate with Eubacterium, Subdoligranulum and Blautia, while exotoxin 9 levels correlated with Dialister, Oscillospira, Lachnospira and Prevotella. This suggests that either the composition of the intestinal microbial flora has the ability to influence levels of both virulent and non-virulent C. concisus strains, or infection with C. concisus may modulate the levels of specific bacterial taxa within the gastrointestinal tract.
INTRODUCTION
Crohn's disease (CD), one form of inflammatory bowel disease (IBD), is a chronic relapsing disease of the gastrointestinal tract (GIT) (Man et al., 2011) . It is well established that intestinal micro-organisms are involved in the aetiology of CD; however, the identity of the microorganism(s) that induce and perpetuate the disease remains a widely debated avenue of research. Recently, our group identified a possible association between Campylobacter concisus and newly diagnosed paediatric CD (Zhang et al., 2009; Man et al., 2010) . These findings in children have been supported by studies in adult CD patients, where a significantly higher prevalence of C. concisus DNA was detected in colonic biopsies of CD patients than in controls (Mahendran et al., 2011) . Moreover, Nielsen et al. (2012) found that, 6 months following diagnosis, 12 % of Danish patients infected with C. concisus were diagnosed with microscopic colitis in contrast to no patients infected with Campylobacter jejuni/ Campylobacter coli.
More recently, Hansen et al. (2013) disputed the involvement of C. concisus in paediatric CD, having found a similar percentage prevalence within CD patients (44.8 %) and controls (38.1 %). However, notably the authors only managed to isolate C. concisus from colonic biopsies of patients with IBD (two with CD and one with ulcerative colitis) (Hansen et al., 2013) , suggesting bacterial load and viability may play a role. Furthermore, it has been established that C. concisus strains are genetically diverse , a factor that has not been addressed in prevalence studies relating to IBD. This genetic diversity has been correlated with differences in the ability of C. concisus strains to survive intracellularly within intestinal epithelial cells . Specifically, four syntenically conserved genes, one of which encodes the putative virulence factor exotoxin 9/DnaI, may be responsible for the 500-fold greater intracellular bacterial levels observed for some strains Deshpande et al., 2013) .
While previous studies relied on PCR to ascertain the presence of C. concisus, this method does not provide detail on bacterial load. Moreover, previous studies have looked at the prevalence of C. concisus without the analysis of possible markers of pathogenesis. Thus, we employed realtime PCR to determine the levels of C. concisus and exotoxin 9/DnaI within faecal samples of CD patients and healthy controls, and correlated these levels with abundances of microbial taxa identified in a subset of subjects.
METHODS
Subjects. A total of 30 children (19 males) attending Sydney Children's Hospital (Randwick, Australia) were recruited (Table 1) . Prior to admission for gastrointestinal endoscopy, colonoscopy and bowel preparation, stool samples from children with newly diagnosed CD (untreated) were collected at home into a sterile collection container (Techno-plas). The samples were frozen immediately at 220 uC and transported frozen to the laboratory, where they were stored at 280 uC until required for DNA extraction. Diagnosis of CD was based upon standard endoscopic, histological and radiological investigations. Faecal specimens from 30 healthy controls (14 males) were collected from family and friends of hospital staff, all of whom were unrelated to the children with CD and were confirmed by a questionnaire to have no underlying gastrointestinal condition or gastrointestinal symptoms at the time of collection of the faecal sample ( Table 2 ). The mean age±SD for the two groups was 11.7±3.0 and 8.3±4.6 for CD and healthy controls, respectively (Tables 1 and 2) . No child had undergone antibiotic or antiinflammatory therapy in the previous 4 weeks. Informed consent was obtained from all children (or their parent/guardian for younger children) to be included in the study. This study was approved by the Research Ethics Committees of the University of New South Wales and the South East Sydney Area Health Service -Eastern Section, Sydney (Ethics nos 03/163, 03/165 and 06/164).
Quantification of C. concisus and exotoxin levels. DNA was extracted from 0.22 g faeces using the QIAamp DNA stool mini kit (Qiagen) according to the manufacturer's instructions. Quantification of the levels of C. concisus and exotoxin 9 DNA was accomplished using real-time PCR on a Rotor Gene 6000 real-time PCR cycler (Qiagen). C. concisus DNA was amplified using the following primers: 59-CTTGTGAAATCCTATGGCTTA-39 (Concisus F) and 59-CTCATTAGAGTGCTCAGCC-39 (Concisus R), which had been previously optimized by Man et al. (2010) . Cycling conditions were 40 cycles of 94 uC for 10 s, 65 uC for 10 s and 72 uC for 30 s. Exotoxin 9 DNA was amplified using the following primers: 59-GAGACAAAGCTGCTTTAT-39 (exotox-F) and 59-CTATCAAGA-TTAAAGCCG-39 (exotox-R), which had been previously optimized by . Cycling conditions were 30 cycles of 94 uC for 20 s, 53 uC for 20 s and 72 uC for 30 s. Each 10 ml reaction contained a mixture of 3 ml 26 SensiMix SYBR kit (Bioline), 10 pmol each primer, 1 ml DNA template and sterile water to complete the volume.
In order to quantify the levels of DNA in the sample, standard curves were constructed for both the C. concisus PCR and exotoxin 9 PCR employing a range of ten concentrations (1, 5, 10, 25, 50, 80, 100, 200 , 500 and 1000 pg DNA) to obtain a linear plot. The equations for the C. concisus (r50.958) and exotoxin 9 (r50.997) PCRs were log 10 (C. concisus DNA concentration)5(C T value212.294)/(23.5779) and log 10 (exotoxin 9 concentration)5(C T value214.342)/(23.1147), respectively. DNA concentrations were calculated from the C T values of unknown samples employing the respective standard curve. Percentage SE errors were calculated based on the deviation of the concentration of the positive control from the actual concentration (C. concisus PCR, 12 %; exotoxin 9 PCR, 4 %).
Analysis of microbial communities. The microbial community within a subset of samples was previously assessed by high-throughput sequencing of the 16S rRNA gene in . Briefly, Tag-encoded FLX amplicon pyrosequencing (bTEFAP) was performed as described elsewhere using the primers Gray28F (59-TTTGATCNTG-GCTCAG) and Gray519r (59-GTNTTACNGCGGCKGCTG) (Bailey et al., 2010) . Generation of the sequencing library utilized a one-step PCR with a total of 30 cycles, a mixture of Hot Start and HotStar HiFidelity Taq polymerases, and amplicons originating and sequencing extending from the 28F with a mean read length of 400 bp. bTEFAP analyses utilized a Roche 454 FLX instrument with Titanium reagents. The sequence data derived from the high-throughput sequencing process were analysed employing a pipeline developed at Molecular Research LP. Pearson correlation coefficients were calculated based on relative abundances of bacterial groups using GraphPad Prism version 5.0 (GraphPad Software).
RESULTS
This study recruited 30 children with newly diagnosed CD and 30 healthy subjects to serve as controls (Tables 1 and  2 ). A total of 17 of the 30 CD patients (56.7 %) had moderate to severe disease [paediatric CD activity index (PCDAI) ¢30], while 13 patients had mild disease (PCDAI ,30) ( Table 1) . A total of 27 of the 30 patients (90.0 %) had ileocolonic disease (L3), of which 92.6 % (n525) had upper GIT involvement (L4) ( Table 1) . Two patients had colonic disease with upper GIT involvement, whereas only one had ileal disease with upper GIT involvement ( Table 1 ).
The levels of C. concisus DNA were quantified within faecal samples of CD patients and healthy controls. A total of 25 of the 30 CD patients (83.3 %) and 23 of the 30 healthy controls (76.7 %) were found to be positive for the presence of C. concisus DNA, and the levels were shown to be 87 923±84 085 fg (g faeces) 21 for CD patients and 606±376 fg (g of faeces)
21 for healthy controls (Tables 1  and 2 ). While there appeared to be 145-fold more C. concisus DNA in faecal samples from CD patients than healthy controls, this difference was not significant (P50.30). This was due to the high variability within the samples as witnessed by the high SEM. Similarly, CD patients had higher levels (~18-fold) of exotoxin 9/DnaI [111±65 pg (g faeces)
21
] than healthy controls [6.2± 2.1 pg (g faeces)
]; however, again this difference showed a trend but did not reach significance (P50.11; Tables 1  and 2 ). Upon further examination of the results, two CD patients and two healthy controls were considered outliers, due to the high level of C. concisus detected relative to the mean (Tables 1 and 2 ). Calculation of the levels of C.
concisus and exotoxin 9 DNA from the remaining subjects showed that both C. concisus and exotoxin 9 levels remained higher in the CD patients [C. concisus, 320±83 fg (g faeces)
; exotoxin 9, 48.8±20.7 pg (g faeces)
] than in the healthy controls [C. concisus, 249±120 fg (g faeces) 21 ; exotoxin 9, 4.3±1.1 pg (g faeces)
; Tables 1 and 2] . A definite trend (P50.11) was observed in the higher levels of C. concisus DNA in CD patients than in healthy controls. In contrast, the levels of exotoxin 9 were significantly higher (~11-fold, P50.037) in the CD patients than in the healthy controls.
A correlation between the levels of C. concisus and exotoxin 9 was observed when coefficients were calculated for all subjects (CD and healthy controls combined) before (r50.95, P,0.0001) and after (r50.44, P50.0007) adjustment of the data (removal of outliers). Interestingly, however, this correlation between C. concisus and exotoxin 9 was only found in CD patients (before r50.95, P,0.0001; after r50.52, P50.0046) and not in the healthy controls (before r50.23, P50.21; after r50.10, P50.61).
We further examined possible correlations between gender, age, disease location and severity and levels of C. concisus and exotoxin 9 DNA. No differences were observed in C. concisus or exotoxin 9 levels between males and females in either subject group before or after removal of outliers. As the majority of patients had ileocolonic disease with upper GIT involvement, no analyses were performed on disease location. However, it is worth noting that the only patient with ileal disease did not have either C. concisus or exotoxin 9 DNA, and the two patients without upper GIT involvement both had low levels of exotoxin 9 (Table 1) . While initial analyses showed that a correlation between PCDAI and both C. concisus and exotoxin 9 might exist, adjustment of the data to remove outliers abolished any ] even after adjustment; however, this difference was not significant (P50.46). With respect to age, a negative trend was observed with exotoxin 9 levels in CD patients (r520.35, P50.069).
We then looked at the correlation of C. concisus and exotoxin 9 levels with the abundances of bacterial genera within the same subjects (Table 3) . No negative correlations were observed. C. concisus levels correlated with abundances of Eubacterium, Subdoligranulum and Blautia (Table 3) . The Eubacterium and Subdoligranulum species contributing to the correlations were not classified. In contrast, Blautia producta (r50.74, P50.0001) was identified to be the species contributing to the correlation between levels of Blautia and C. concisus. Levels of exotoxin 9 correlated with levels of Dialister, Oscillospira, Lachnospira and Prevotella. The species contributing to these correlations were Dialister invisus (r50.66, P50.001), Lachnospira pectinoschiza (r50.52, P50.02) and Prevotella copri (r50.54, P50.01).
DISCUSSION
Possible reasons for the conflicting findings on the association of C. concisus with CD may relate to the abundance of C. concisus in samples or variations in the prevalence of non-pathogenic C. concisus in different populations. To clarify this, we quantified the levels of C. concisus and exotoxin 9 DNA in faecal samples of CD patients and controls. This showed a similar prevalence of C. concisus to be present in CD patients and controls, which most likely resulted from the high sensitivity of the Table 3 . Correlation of C. concisus and exotoxin 9 levels (±SEM) with bacterial taxa in patients with CD and healthy controls Campylobacter concisus and Crohn's disease real-time PCR assay employed in this study. Upon further analysis, the levels of C. concisus were found to be higher in CD patients than healthy controls, although this did not reach significance (P50.11). Analysis of exotoxin 9 found significantly higher levels in CD patients than healthy controls (P50.037), suggesting not only that CD patients had higher levels of C. concisus but also that their strains were likely to be more virulent. Moreover, the levels of C. concisus correlated with the exotoxin 9 levels in the CD patients but not in the healthy controls, indicating that healthy controls are likely to be colonized by non-virulent C. concisus strains. This finding may have contributed to the lack of significance observed in this study for the higher levels of C. concisus in the CD patients compared with the healthy controls. Interestingly, a negative trend emerged between age of the CD patient and exotoxin 9 levels, which suggested that younger patients had higher levels of virulent C. concisus, supporting previous evidence that C. concisus infection is associated with younger children (Aabenhus et al., 2002; Lastovica, 2009; Nielsen et al., 2013) .
The C. concisus levels in the two CD patients considered outliers (CD9 and CD20) were over 300-fold and 7000-fold higher than the mean level of the rest of the samples, and both of these patients had high PCDAI scores. Analysis of the microbiota of patient CD9 indicated a high level of Fusobacterium equinum (27.4 %; present in only one other CD patient, at 0.028 %) . This bacterium has been isolated from the oral cavity and associated with oral disease in horses (Dorsch et al., 2001) , suggesting an interplay between pathogenic species. This variability in C. concisus levels is also found in the healthy controls, with HC12 and HC17 both reporting 40-fold and 10-fold higher levels than the mean of the rest of the controls. Interestingly, the involvement of the intestinal microbiota in this phenomenon can also be seen, with HC12 being classified as an outlier compared with other controls in our previous study . This exclusion was largely due to the high levels of P. copri (55.2 %) , which is now classified as a Prevotella entero-type possibly associated with long-term diet (Wu et al., 2011) . Thus, it is conceivable that subjects with specific entero-types may have higher levels of C. concisus or that C. concisus levels may be influenced by diet, particularly if these factors increase the levels of H 2 within the colon.
As a result of these findings, we correlated the levels of C. concisus and exotoxin 9 with the abundances of microbial taxa, and found C. concisus levels to positively correlate with the levels of Eubacterium, Subdoligranulum and Blautia (B. producta). These three genera are related and belong to the order Clostridiales within the phylum Firmicutes. Both Subdoligranulum and Blautia are high producers of short-chain fatty acids (Holmstrøm et al., 2004; Liu et al., 2008) , and these may serve as energy sources for C. concisus. Alternatively, the presence of C. concisus may be driving the higher abundances of these bacterial genera. Exotoxin 9 levels correlated with Dialister (D. invisus), Oscillospira, Lachnospira (L. pectinoschiza) and Prevotella (P. copri). Similarly to the above, both Oscillospira and Lachnospira belong to the order Clostridiales within the phylum Firmicutes. The correlation of C. concisus with D. invisus is of great interest as both organisms are found within the human oral cavity (Downes et al., 2003; , and D. invisus has been associated with periodontal disease (Siqueira & Rô ças, 2009 ).
This study is not without limitations. The varying liquidity of faecal specimens from disorders with diarrhoea may have contributed to the large variations seen within our results. However, this is unlikely to have resulted in the higher levels of C. concisus and exotoxin 9 DNA observed in CD patients as compared with controls, since the liquidity of the faecal samples from CD patients would be expected to result in an underestimation of DNA levels. Moreover, confirmation of these findings in larger cohorts of CD patients and controls, in different populations and in intestinal biopsy samples is clearly required.
Nevertheless, our results suggest that either the composition of the intestinal microbial flora has an ability to influence the levels of both virulent and non-virulent C. concisus strains, or infection with C. concisus may modulate the levels of particular bacterial taxa within the GIT. Moreover, a possible association between infection with C. concisus and the abundance of oral pathogens within the GIT was identified. In conclusion, this study has provided further evidence to support a role for virulent C. concisus strains in CD. Further studies with larger cohorts of patients and controls are required to validate these findings.
